Log in to save to my catalogue

Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis...

Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7952348

Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry

About this item

Full title

Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Rheumatology international, 2021-04, Vol.41 (4), p.751-762

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

To examine whether treatment with interleukin (IL)-1-, IL-6-, tumour necrosis factor α (TNFα)-inhibitors or Abatacept is associated with an increased risk of common infections, infections requiring hospitalization (SAE) or opportunistic infections among real-world juvenile idiopathic arthritis (JIA) patients. Furthermore, the influence of other pat...

Alternative Titles

Full title

Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7952348

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7952348

Other Identifiers

ISSN

0172-8172

E-ISSN

1437-160X

DOI

10.1007/s00296-020-04774-3

How to access this item